Credit Agricole

Credit Agricole’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Credit Agricole’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,000	Closed	-$2.52K	–	736
2023 Q1	$2.52K	Hold	7,000	–	–	﹤0.01%	624
2022 Q4	$6.2K	Hold	7,000	–	–	﹤0.01%	641
2022 Q3	$11K	Hold	7,000	–	–	﹤0.01%	604
2022 Q2	$14K	Hold	7,000	–	–	﹤0.01%	591
2022 Q1	$16K	Hold	7,000	–	–	﹤0.01%	612
2021 Q4	$33K	Hold	7,000	–	–	﹤0.01%	576
2021 Q3	$53K	Hold	7,000	–	–	﹤0.01%	502
2021 Q2	$68K	Buy	7,000 +2,000	+40%	+$15.9K	﹤0.01%	464
2021 Q1	$41K	Buy	+5,000	New	+$52.8K	﹤0.01%	470

Other funds holding SRNE

SlateStone Wealth Jupiter, Florida $1.21B AUM 21.86% 1-Year Est. Return

KLCM Advisors Milwaukee, Wisconsin $1.15B AUM 34.45% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Russell Investments Group

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return